City of Hope (T Cell Manufacturing) vs Merck KGaA / MilliporeSigma (CDMO): CDMO Comparison

Side-by-side comparison of City of Hope (T Cell Manufacturing) and Merck KGaA / MilliporeSigma (CDMO) on independent FDA inspections, EMA and MHRA GMP certificates, clinical-program activity, and CDMO Signal Score. Data sourced from FDA, EMA EudraGMDP, MHRA GMDP, and ClinicalTrials.gov.

Duarte, CA
Signal Score
84/100
Quality (FDA + GMP)
97/100
FDA inspections
3
— NAI / VAI / OAI
2 / 1 / 0
FDA warning letters
0
EMA GMP certificates (active)
0
MHRA GMP certificates (compliant)
0
Clinical programs (matched)
209
Capacity
Modalities
CAR-T, Cell Therapy
Darmstadt, DE · St. Louis, MO
Signal Score
82/100
Quality (FDA + GMP)
99/100
FDA inspections
2
— NAI / VAI / OAI
0 / 2 / 0
FDA warning letters
0
EMA GMP certificates (active)
2
MHRA GMP certificates (compliant)
0
Clinical programs (matched)
22
Capacity
Modalities
mRNA, Biologics, Cell Therapy

Key differences

  • Both maintain clean enforcement records — no FDA OAI classifications or warning letters on file for either CDMO.
  • Merck KGaA / MilliporeSigma (CDMO) holds 2 active EMA GMP certificates; City of Hope (T Cell Manufacturing) does not appear in EudraGMDP.
  • City of Hope (T Cell Manufacturing) appears as a manufacturing partner on more matched clinical programs (209 vs 22) — a broader sponsor book.

On a 13-modality CDMO landscape, both City of Hope (T Cell Manufacturing) and Merck KGaA / MilliporeSigma (CDMO) qualify as Cell Therapy manufacturers; City of Hope (T Cell Manufacturing) carries the higher composite Signal Score for Cell Therapy programs in this comparison.

What to evaluate for Cell Therapy programs

Both City of Hope (T Cell Manufacturing) and Merck KGaA / MilliporeSigma (CDMO) qualify as Cell Therapy CDMOs. When choosing between them for Cell Therapy programs, weigh these four dimensions specifically — each carries through to the side-by-side scorecard above.

Autologous vs allogeneic

Autologous needs per-patient scheduling, chain-of-identity, and short turnaround; allogeneic needs scalable batch processing and a master cell bank strategy. Pick a CDMO proven in your model.

Vector & raw materials

Most cell therapies need a viral vector. Confirm whether the CDMO makes vector in-house or coordinates an external supplier, and how that affects timelines.

Closed-system & cleanrooms

Closed, automated processing reduces contamination risk and labor. Ask about cleanroom grade, automation platforms, and parallel-suite capacity.

Cold chain & logistics

Cryopreservation and chain-of-custody are critical for living cells. Evaluate the CDMO's cold-chain and apheresis-to-infusion logistics.

See all Cell Therapy CDMOs ranked by Signal Score →

Frequently asked: City of Hope (T Cell Manufacturing) vs Merck KGaA / MilliporeSigma (CDMO)

Which has the stronger FDA inspection record, City of Hope (T Cell Manufacturing) or Merck KGaA / MilliporeSigma (CDMO)?

Both City of Hope (T Cell Manufacturing) and Merck KGaA / MilliporeSigma (CDMO) maintain clean enforcement records on file — no FDA warning letters and no OAI classifications. City of Hope (T Cell Manufacturing) has 3 FDA inspections on record; Merck KGaA / MilliporeSigma (CDMO) has 2.

How do City of Hope (T Cell Manufacturing) and Merck KGaA / MilliporeSigma (CDMO) compare on European GMP coverage?

City of Hope (T Cell Manufacturing) holds 0 active EMA GMP certificates and 0 MHRA / UK certificates. Merck KGaA / MilliporeSigma (CDMO) holds 2 active EMA GMP certificates and 0 MHRA / UK certificates. Use these counts as a proxy for the breadth of each CDMO's European regulatory footprint.

Which is more active in clinical-stage manufacturing — City of Hope (T Cell Manufacturing) or Merck KGaA / MilliporeSigma (CDMO)?

City of Hope (T Cell Manufacturing) is matched to 209 ClinicalTrials.gov records as a manufacturing partner; Merck KGaA / MilliporeSigma (CDMO) is matched to 22. Higher counts indicate broader sponsor exposure but say nothing about approved-product track record — pair this number with each CDMO's profile page for context.

Which is better for Cell Therapy manufacturing — City of Hope (T Cell Manufacturing) or Merck KGaA / MilliporeSigma (CDMO)?

Both City of Hope (T Cell Manufacturing) and Merck KGaA / MilliporeSigma (CDMO) are tagged as Cell Therapy CDMOs in our directory, so both are credible options for Cell Therapy programs. The most important differentiator for Cell Therapy selection is typically autologous vs allogeneic: Autologous needs per-patient scheduling, chain-of-identity, and short turnaround; allogeneic needs scalable batch processing and a master cell bank strategy. Pick a CDMO proven in your model. Review each CDMO's profile and inspection record before shortlisting.

What does the Signal Score gap mean in practice?

City of Hope (T Cell Manufacturing) carries a Signal Score of 84/100 and Merck KGaA / MilliporeSigma (CDMO) carries 82/100 — essentially tied for City of Hope (T Cell Manufacturing). The Signal Score combines quality (FDA inspections + EMA/MHRA GMP), operational performance, financial stability, and capacity intelligence. CDMOs cannot pay to influence their score.

Evaluating City of Hope (T Cell Manufacturing) and Merck KGaA / MilliporeSigma (CDMO) for a program?

Use the free AI matchmaker to weigh both against your specific requirements — capacity, modality, regulatory record, geography — and surface other qualified options.

Find & compare CDMOs →
Sourced from FDA, EMA EudraGMDP, MHRA GMDP, and ClinicalTrials.gov.